Edoardo Cignoli : Mylan Earnings Rise on Specialty Segment Growth

Mylan Inc. said its fourth-quarter earnings rose 11% as the generic-drug company said revenue growth in its specialty segment and strength in its foreign generics business offset a decline in new product revenue.



via WSJ.com: US Business http://ift.tt/1fL6X0n